{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:08:36Z","timestamp":1785553716874,"version":"3.56.0"},"reference-count":39,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>BACKGROUND: Psoriasis is frequently accompanied by metabolic syndrome. Effect of anti-tumor necrosis factor therapies on increases in body weight is well-known. Data on the effects of interleukin-17 inhibitors are limited. Authors determined the effect of anti-interleukin-17 therapies on the body composition and serum lipid and inflammatory parameters among severe psoriatic patients. METHODS: Thirty-five severe psoriatic patients were enrolled. Twenty-two received secukinumab and 13 received ixekizumab as their 2nd-or 3rd-line biological treatment. Before treatment initiation and 6 months later, laboratory examinations measuring metabolic and inflammatory panels and body composition analyses were performed. RESULTS: After 6 months, a significant reduction was observed in psoriasis area severity index (p &lt; 0.001) from 18 to 0, in c-reactive protein (p &lt; 0.001) from 6.6 to 4.00 mg\/L, in low-density lipoprotein-cholesterol (p = 0.004) from 3.69 to 3.19 mmol\/L, and an improvement in high-density lipoprotein-cholesterol (p = 0.022) from 1.31 to 1.40 mmol\/L. Median baseline body mass index was 32.80 kg\/m2. The body composition parameters did not show any significant changes. CONCLUSIONS: Anti-interleukin-17 therapy of severe psoriatic patients does not cause significant changes in body composition parameters. Improvements in the lipid and inflammatory parameters might have a beneficial effect on patients\u2019 cardiometabolic status. This effect might be detectable in high-risk obese psoriatic patients.<\/jats:p>","DOI":"10.3390\/life11060535","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T04:22:22Z","timestamp":1623212542000},"page":"535","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters\u2019 Levels, but Has No Effect on Body Composition Parameters"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7131-9682","authenticated-orcid":false,"given":"\u00c9va Anna","family":"Piros","sequence":"first","affiliation":[{"name":"Department of Dermatology, Venereology and Dermato-Oncology, Semmelweis University, 1085 Budapest, Hungary"},{"name":"R\u00e1cz K\u00e1roly Doctoral School of Clinical Medicine, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1kos","family":"Szab\u00f3","sequence":"additional","affiliation":[{"name":"R\u00e1cz K\u00e1roly Doctoral School of Clinical Medicine, Semmelweis University, 1085 Budapest, Hungary"},{"name":"Department of Health Economics, Corvinus University, 1093 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9674-620X","authenticated-orcid":false,"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[{"name":"Department of Health Economics, Corvinus University, 1093 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6095-2295","authenticated-orcid":false,"given":"Valentin","family":"Brodszky","sequence":"additional","affiliation":[{"name":"Department of Health Economics, Corvinus University, 1093 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wikonk\u00e1l","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermato-Oncology, Semmelweis University, 1085 Budapest, Hungary"},{"name":"Military Hospital-State Health Centre, 1134 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1l","family":"Miheller","sequence":"additional","affiliation":[{"name":"1st Department of Surgery and Interventional Gastroenterology, Semmelweis University, 1082 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0661-3388","authenticated-orcid":false,"given":"Mikl\u00f3s","family":"Horv\u00e1th","sequence":"additional","affiliation":[{"name":"1st Department of Surgery and Interventional Gastroenterology, Semmelweis University, 1082 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Holl\u00f3","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Dermato-Oncology, Semmelweis University, 1085 Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","article-title":"Diagnosis and classification of psoriasis","volume":"13","author":"Raychaudhuri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2147\/PTT.S64950","article-title":"Current knowledge on psoriasis and autoimmune diseases","volume":"6","author":"McCormick","year":"2016","journal-title":"Psoriasis Targets Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Toussirot, \u00c3., Aubin, F., Dumoulin, G., Toussirot, \u00c9., and Aubin, F. (2014). Relationships between Adipose Tissue and Psoriasis, with or without Arthritis. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00368"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"775.e1","DOI":"10.1016\/j.amjmed.2011.03.028","article-title":"Attributable Risk Estimate of Severe Psoriasis on Major Cardiovascular Events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1590\/1806-9282.64.04.368","article-title":"Metabolic syndrome and psoriasis: A study in 97 patients","volume":"64","author":"Ferdinando","year":"2018","journal-title":"Revista Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","article-title":"Bioelectrical impedance analysis--part I: Review of principles and methods","volume":"23","author":"Kyle","year":"2004","journal-title":"Clin Nutr."},{"key":"ref_10","first-page":"1180","article-title":"Phase Angle Measurement in Healthy Human Subjects through Bio-Impedance Analysis","volume":"15","author":"Kumar","year":"2012","journal-title":"Iran J. Basic Med. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1540-8159.2012.03377.x","article-title":"Effect of Bioimpedance Body Composition Analysis on Function of Implanted Cardiac Devices","volume":"35","author":"Buch","year":"2012","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.ad.2017.07.002","article-title":"Moderate Psoriasis: A Pro-posed Definition","volume":"108","author":"Notario","year":"2017","journal-title":"Actas Dermosifiliogr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jdermsci.2008.04.016","article-title":"Combined effects of HLA-Cw6, body mass index and waist\u2013hip ratio on psoriasis vulgaris in Chinese Han population","volume":"52","author":"Jin","year":"2008","journal-title":"J. Dermatol. Sci."},{"key":"ref_14","first-page":"1","article-title":"The Influence of FTO Polymorphism rs9939609 on Obesity, Some Clinical Features, and Disturbance of Carbohydrate Metabolism in Patients with Psoriasis","volume":"2019","author":"Szepietowski","year":"2019","journal-title":"BioMed. Res. Int."},{"key":"ref_15","first-page":"3096","article-title":"IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications","volume":"10","author":"Boehncke","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chehimi, M., Vidal, H., and Eljaafari, A. (2017). Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases. J. Clin. Med., 6.","DOI":"10.3390\/jcm6070068"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbrc.2016.06.049","article-title":"IL-17A synergistically enhances TNF\u03b1-induced IL-6 and CCL20 production in 3T3-L1 adipocytes","volume":"477","author":"Shinjo","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bcp.2009.03.008","article-title":"Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes","volume":"77","author":"Shin","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/09546634.2019.1621979","article-title":"Adiponectin levels in a large pooled plaque psoriasis study population","volume":"31","author":"Gerdes","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5114\/pdia.2014.40960","article-title":"Effect of psoriasis activity on serum adiponectin and leptin levels","volume":"2","author":"Baran","year":"2015","journal-title":"Adv. Dermatol. Allergol."},{"key":"ref_23","first-page":"93","article-title":"Antibodies towards high-density lipoprotein components in patients with psoriasis","volume":"312","author":"Batuca","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/ajd.12044","article-title":"Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis","volume":"54","author":"Tan","year":"2013","journal-title":"Australas. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.phrs.2008.02.006","article-title":"Effect of anti-tumor necrosis factor-\u03b1 therapies on body mass index in patients with psoriasis","volume":"57","author":"Saraceno","year":"2008","journal-title":"Pharmacol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.2011.03991.x","article-title":"Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity","volume":"25","author":"Sbidian","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40257-016-0211-7","article-title":"Considerations for Systemic Treatment of Psoriasis in Obese Patients","volume":"17","author":"Gisondi","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bjd.12235","article-title":"Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: A prospective cohort study","volume":"168","author":"Gisondi","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/bjd.16008","article-title":"Efficacy of guselkumab in subpopulations of patients with moderate-to-severe plaque psoriasis: A pooled analysis of the phase III VOYAGE 1 and VOYAGE 2 studies","volume":"178","author":"Gordon","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/jdv.16521","article-title":"Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: An integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies","volume":"34","author":"Strober","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jdv.16004","article-title":"Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients","volume":"34","author":"Gerdes","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gisondi, P., Bellinato, F., Bruni, M., De Angelis, G., and Girolomoni, G. (2020). Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome. Dermatol. Ther., 33.","DOI":"10.1111\/dth.14281"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wang, H.N., and Huang, Y.H. (2020). Changes in metabolic parameters in psoriatic patients treated with secukinumab. Ther. Adv. Chronic Dis., 11.","DOI":"10.1177\/2040622320944777"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaad.2018.02.074","article-title":"Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3","volume":"79","author":"Egeberg","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2018.10.006","article-title":"Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis","volume":"29","author":"Huang","year":"2019","journal-title":"Cell Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.imbio.2016.10.013","article-title":"Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A\/IL-17 receptor signaling in a murine model","volume":"222","author":"Nadeem","year":"2017","journal-title":"Immunobiology."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of Metabolic Syndrome in Patients with Psoriasis: A Population-Based Study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e013471","DOI":"10.1161\/JAHA.119.013471","article-title":"Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events","volume":"8","author":"Choi","year":"2019","journal-title":"J. Am. Hear. Assoc."},{"key":"ref_39","unstructured":"Physical status: the use and interpretation of anthropometry (1995). Report of a WHO Expert Committee. World Health Organ Tech. Rep. Ser., 854, 1\u2013452."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/6\/535\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:12:18Z","timestamp":1760163138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/6\/535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["life11060535"],"URL":"https:\/\/doi.org\/10.3390\/life11060535","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]}}}